Exousia Bio, Inc. cotiza a 0.02 USD y tiene una capitalización bursátil de $834750. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Consumo defensivo
Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality t…
| Métrica | LMMY | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | -93.4% | 30.7% | -124.0% |
| Operating Margin | — | 1.0% | — |
| Net Margin | 1370.5% | 0.8% | +1369.8% |
| FCF Margin | — | 2.4% | — |
| ROE | — | 5.2% | — |
| ROA | — | 0.6% | — |
| Current Ratio | — | 1.35 | — |
| Debt / Equity | — | 0.37 | — |